Hexarelin dose range

The amounts people commonly use, from the low end to the high end, with syringe units, schedule and half-life. The 8 published studies are one click away.

Small human studies Growth hormone axis Also called Examorelin, EP-23905

Common use ranges

From user guides and clinic write-ups. No drug label exists, and no study has tested these amounts in people. No drug label. Only one comparison guide gives amounts: 100 to 200 mcg a shot, 2 to 3 times a day.

Sources disagree, or there are very few. The amounts below come from a small number of guides, and they do not line up well. Treat every number on this page as uncertain, and check each source yourself.

Half-life
about 76 minutes in rats
How it is taken
subcutaneous injection
How long people use it
Not stated by the source.
Mixing used for the units
5 mg vial + 2 mL water. 1 unit on a U-100 insulin syringe = 25 mcg.
Total amount per day, by tier
Starting200 mcg / dayTypical300 mcg / dayHigher600 mcg / day
TierEach doseSyringe units5 mg vial + 2 mL waterHow oftenScheduleVial lastsat this tier
Starting [1]100 mcg4 units 0.04 mL2x a day100 mcg 2 times a dayabout 4 weeks
Typical [2]100 mcg4 units 0.04 mL3x a day100 mcg 3 times a day16 days
Higher [3]200 mcg8 units 0.08 mL3x a day200 mcg 2 to 3 times a day8 days

Sources for these amounts

  1. Starting: Peptide-DB, GHRP-6 vs hexarelin
  2. Typical: Peptide-DB, GHRP-6 vs hexarelin
  3. Higher: Peptide-DB, GHRP-6 vs hexarelin

Half-life: Roumi et al 2000, Drug Metab Dispos, kinetics and disposition in rats

This page shows what labels, clinics and users report, and what studies gave. It is not medical advice and not a recommendation for anyone. Many of these compounds are not approved for human use. Check your own medicines and lab work with a licensed clinician before using anything.

See the science: 8 published studies

Amounts given to people in studies

Lowest0.25 micrograms per kilogram, one time, into a vein
Most used2 micrograms per kilogram, one time, into a vein
Highest2 micrograms per kilogram, one time, into a vein

How it was given: into a vein for the one-time tests, under the skin for the one long study

The only repeated-use study used 1.5 micrograms per kilogram under the skin, twice a day.

Amounts given to animals in studies

Lowest1 microgram per kilogram, one time (rat)
Most used5 micrograms per kilogram, one time (rat)
Highest50 micrograms per kilogram, one time (rat)

Read this first. In the only 16-week study the growth hormone response dulled by week 4 and IGF-1 never moved. Swallowed hexarelin barely works, about 0.3 percent gets through.

Every study used for this page

Proof grade: Small human studies. Only small or uncontrolled human studies. Amounts are quoted as each study reported them. Where the abstract does not state an amount, the row says so.

StudyWho was studiedAmount given, as reportedRouteHow oftenHow longWhat the authors reported
PMID 9404449Arvat et al, Clin Endocrinol 1997Human, 6 healthy men aged 24 to 300.25, 0.5 and 2.0 mcgrams/kgInto a veinOne time per dose levelSingle dosesGrowth hormone rose more as the amount rose
PMID 9156035Loche et al, Clin Endocrinol 1997Human, 8 healthy men aged 21 to 332 mcgrams/kgInjection, route not in abstractOne time, morning and again at nightSingle dosesPeak growth hormone about the same awake and asleep
PMID 7962341Arvat et al, J Clin Endocrinol Metab 1994Human, 13 young and 16 elderly men2 mcgrams/kgInto a veinOne time per sessionSingle dosesResponse was much weaker in the elderly, arginine restored it
PMID 9253314Ghigo et al, J Clin Endocrinol Metab 1997Human, 12 healthy adults plus Cushing's patients2.0 mcgrams/kgInto a veinOne timeSingle doseAlso pushed up ACTH and cortisol, like CRH does
PMID 11322491Broglio et al, Endocrine 2001Human, 7 healthy adults, 7 growth-hormone-deficient, 12 with an enlarged weak heart2.0 mcgrams/kgInto a veinOne timeSingle dose, followed 60 minutesSqueezed the heart harder in the first two groups, no blood pressure change
PMID 9589671Rahim et al, J Clin Endocrinol Metab 1998Human, adults (n not in abstract)1.5 mcgrams/kgUnder the skinTwice a day16 weeks, plus 4 weeks offThe growth hormone response dulled part way and came back after stopping, IGF-1 never moved
PMID 10611139Roumi et al, Drug Metab Dispos 2000Rat, male Sprague-Dawley5 mcgrams/kg into a vein, 5, 10 and 50 mcgrams/kg under the skinInto a vein, and under the skinOne timeSingle dosesClearing half of it took 76 minutes, 64% got in from a skin shot
PMID 11578108Westberg et al, J Pharm Pharmacol 2001Human, plus rat gut tissueNot stated in the abstractBy mouthOne timeSingle doseOnly 0.3% of a swallowed dose worked, gut trypsin breaks it up

How to read the study numbers

  • One study, one group. Each figure is what one team chose for its own participants or animals.
  • Route matters. An amount given into a vein (IV) is not the same as the same amount under the skin, in the nose or by mouth.
  • Animals are not small people. An animal amount is shown as the study gave it. It is not a human amount.
  • Short studies. Many studies ran days or weeks. They do not show what happens over longer use.

Common questions

What amounts of Hexarelin were used in human studies?

In the studies listed here, people were given from 0.25 micrograms per kilogram, one time, into a vein up to 2 micrograms per kilogram, one time, into a vein. The amount used most often was 2 micrograms per kilogram, one time, into a vein. These are what study teams chose for their participants under supervision.

Where do these Hexarelin numbers come from?

From 8 published studies, each linked to its PubMed or ClinicalTrials.gov record. Every figure was checked against the study abstract or its open full text. Proof grade: Small human studies.

How long does Hexarelin stay in the body?

Its half-life is about 76 minutes in rats, measured in animals, not people. Half-life is how long it takes for half of a dose to leave the blood. The effect can last longer than that.

Is this a recommendation for how much Hexarelin to use?

No. This page shows the amounts reported by drug labels, clinics and users, next to what researchers gave in studies. It is not medical advice and not a recommendation for anyone. Talk to a licensed clinician before using any of it.

See all peptides